Business
Description:
The Company
produces and distributes a product line of pediatric and adult OTC
(over-the-counter) supplements that treat nutritional iron deficiency. The Company has completed clinical trials
that prove its products to be safe, effective, and well tolerated with a higher
level of palatability than its global competitor’s major brands. Product line ranges from pediatric to adult
with leading revenue generators centering on pediatrics due to the critical
need for proper iron levels in children starting at birth.
Distribution:
U.S.A.
/ Global
Operational
Strengths:
The products
are produced in a USA FDA registered pharmaceutical contract manufacturing
plant. Products have FDA registered
labeler code and GS1 (global supply chain) certified SKU codes. NDC (National Drug Codes) are registered with
the FDA, DailyMed, FirstData, Medi-Span and Wolters Kluwer. The founder is a seasoned pharmaceutical
professional with over 30 years industry experience and intends to remain post-closing.
The
Transaction:
Transaction will result in the buy-out of
non-active start up shareholders and fold back-office operations into the
buyer’s existing operations. Founder
seeks ONLY investment partners with an established OTC distribution and
marketing platform. Founder’s strategic
plan is to lead the company into the future and expand sales by partnering with
experienced, established OTC investors.
Key
Investment Considerations:
·
Seasoned
Pharmaceutical Co. with Branded/Trusted product line.
·
Very
strong industry niche.
·
Registered
trademark in US, CA and EU.
·
High
profit margins.
·
Large
client base and growing.
·
Highest
online ranking in its category, Amazon, Etailz, etc.
·
Global
presence.
·
Products
registered with the FDA.
·
Products
Kosher and Vegan Verified.
·
All
products, Ingredients and Packaging manufactured in USA FDA cGMP (Certified
Good Manufacturing Practices) facility.
Financial
Summary
|
|||
2019
|
2018
|
2017
|
|
Revenue
|
$2.7
MM
|
$2.4
MM
|
$1.7
MM
|
Adjusted EBITDA
|
$1.2 MM (44%)
|
$1.3 MM (54%)
|
726 K (43%)
|
Other Highlights
|
||||
Location
|
Financials
|
Management Team in Place
|
Years in Business
|
SIC Classification
|
Central
|
Complied
|
Yes
|
5+
|
325410
|
Direct All Inquiries to:
Gottesman Company
Refer to: S-1874 RS AJR
Tel: 718-618-5346 UK Office: +44 (0) 7906786505
Email: dmj@gottesman-company.com